Categories: Automobile

NYSE Content Advisory: Pre-Market Update + BETA Technologies Ends First Day of Trading Higher

NEW YORK, Nov. 5, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Ashley Mastronardi delivers the pre-market update on November 5th

- Advertisement -
  • Equities are down this morning as markets took a breather yesterday. Investors showed concern about high valuations in AI leaders. Looking ahead, earnings season continues with NYSE-listed enterprises including Snap, Figma, and E.L.F.
  • Beta Technologies (NYSE: BETA) made its NYSE debut yesterday. The firm’s shares ended its first day of trading up almost 6% at $36 a share, with an almost $7.6 billion valuation.
  • The NYSE will be diving deeper into the space industry with Arkaea. Teaming up monthly, they will provide viewers with the latest look on the companies, investors, and innovations shaping the frontier economy.
  • The AD Council and Opportunity-At-Work today unveiled a new PSA titled ‘Story Unfold,’ which encourages employers to embrace skills-first hiring practices and access overlooked talent.


Opening Bell


HP (NYSE: HPQ) celebrates the 10th anniversary of the HPE spin-off

- Advertisement -


Closing Bell


RingCentral (NYSE: RNG) celebrates powering the future of AI communications

- Advertisement -


Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2814536/NYSE_Market_Update_November_5.mp4 
Logo – https://mma.prnewswire.com/media/2581322/5603774/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–beta-technologies-ends-first-day-of-trading-higher-302605695.html

- Advertisement -
PRNW Agency

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

6 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago